Drug-resistant mutants of somatic cell lines fall into two classes: one seems to correspond to classical gene mutation, the other is characterized, albeit transiently, by karyotypic instability, high reversion frequency, and low plating efficiency. An interpretation of the origin of these drug-resistant mutants is offered on the basis of chromosomal variation, which generates variation of the number of copies of each individual chromosome and, consequently, of gene dosage.
The behavior of somatic cell mutants presents a number of unresolved paradoxes (for general reference see ref. 1). In particular, although the Luria-Delbruck fluctuation analysis, when applied, indicates that variants arise at random and independently of the selective agent, the lack of effect of mutagenic agents and of the degree of ploidy on the frequency of mutation, has led some authors to postulate epigenetic changes as the basis of drug-resistant phenotypes (2, 3) . Recently, however, evidence for a conventional mutational event was found in structural alteration of the gene product (4) (5) (6) (7) . Considerable evidence, recently confirmed by the application of high-resolution techniques for chromosome identification (8) (9) (10) shows that established cell lines are to be seen as highly heterogeneous populations. Their cytogenetical polymorphism is determined by at least two factors: fitness of overall metabolic balance, and fitness of the chromosomal number relative to certain restrictions posed by the mitotic apparatus (11) . Even when the cells have the same total number of chromosomes, they usually possess a variable number of homologues (10, 12, 13) .
The variation in gene dosage resulting from the variation in the number of homologues (chromosomes or chromosome fragments) may not only have an effect on the frequency of mutants in polyploid populations (14) but may also have a direct effect on the cell phenotype (15) (16) (17) (18) (19) . The direct approach for investigating the phenotypic effects of variations in gene dosage would be to analyze karyotypes. However, since the chromosomal location of the relevant structural and regulatory genes is unknown, an alternative approach is possible if the cells that survive a selective treatment owing to an exceptional gene dosage, are also exceptional in overall chromosomal number. As the mitotic apparatus of these cells tends to adjust to some preferred chromosomal number (11), they would remodel their karyotype. In this process, genetic instability would be revealed by many lethals (causing a low efficiency of plating) and high frequency of reversion.
I will show that by analyzing the behavior of drug-resistant mutants historically, day by day, classical stable mutants can be clearly distinguished from mutants associated with chromosomal variation.
EXPERIMENTAL RESULTS
1. Syrian Hamster Line B.. B1 is a bromodeoxyuridine (BrdUrd)-resistant derivative of BHK, isolated by Littlefield and Basilico who used a step-wise selection procedure (20) .
It grows well in E4 medium (11) containing up to 30 /Ag/ml of BrdUrd, and its thymidine kinase activity (ATP: thymidine 5'-phosphotransferase, EC 2.7.1.75) is only 3% that of the parental strain BHK. Littlefield and Basilico also reported that a 20-fold increase in thymidine kinase activity was associated with reversion.
From a clone of this B1 line, I isolated 24 spontaneous revertants (R) capable of growing in HAT medium (20) and designated them R1 to R24. They occurred at a frequency of 5 X 10-6 which was not changed by treatment with 0.5 pg/ml of nitrosoguanidine for 3 hr (21) . As soon as the revertant clones had reached the size of a few thousand cells some of their properties were analyzed; similar measurements were repeated at later times.
The efficiency of plating of these revertants measured in HAT soon after isolation was between 1 % and 5%; in E4 medium it was not much higher but 1 month later it went back to 30%, which is characteristic of B1. These revertants, if plated en masse, seem to grow both in HAT and BrdUrd. However, this is not a physiological property possessed by all revertant cells, as suggested in other systems (22, 23) , but rather a manifestation of genetic instability. In fact, as shown in Table 1 Cells of the various revertant clones, after isolation in HAT, were subcultured for 1 week in HT. They were then trypsinized and seeded at 103 cells per 50-mm dish in different media. They were allowed to grow for 4 days and were then trypsinized and counted. The ratios of these counts in different media, relative to E4 or HAT, are reported in the table. BrdUrd5 and BrdUrd3O were media containing 5 and 30,g/ml of BrdUrd, respectively. HT is E4 plus hypoxanthine and thymidine. (27) in the DON line for deficiency of thymidine incorporation was also of the same order of magnitude (2.6 X 10-4). These authors also found the mutation rate unaffected by mutagen treatment. BrdUrd-resistance in this line may be due to a deficiency in thymidine transport rather than to the activity of thymidine kinase (27) . Among the clones obtained by plating DON in 5 ig/ml of BrdUrd, I isolated 10 resistant colonies, designated BU1 to 10. They are characterized by low efficiency of plating in E4 A BrdUrd, strongly dependent on the concentration of the drug, by high reversion rate, and by instability of the karyotype. Not all tests were done on all clones.
The chromosomal distribution of BUl, followed at different times, shows a decrease in variability and a stabilization in the diploid range. These and other histograms (BU6 and BU9) are presented in Fig. 1 together with the chromosome distribution of DON.
Clone BU8 plated with an efficiency of 3.7% in E4, 1.66% in 5 sg/ml BrdUrd, 0.28% in 15 ,g/ml of BrdUrd, and 0.01% in 30 sg of BrdUrd/ml. In HAT, the efficiency was 1.83%. From the efficiencies in HAT and E4, the reversion frequency would be calculated as 0.5. BU6 was plated in Linbro trays at 0.2 cells per well (ten trays were used for each medium). Six clones were recovered in E4, five in HAT and only one in 5 /4g of BrdUrd. All these clones were replated in E4 medium plus hypoxanthine and thymidine (HT), HAT, and BrdUrd (see Table 3 ). A high reversion rate was found for the BU6 mutation and for its revertants as well. In general there was a tendency to evolve towards the wild-type constitution, in the sense that without selection, the HAT-resistant type becomes much more frequent than the BrdUrd-resistant type.
No spontaneous mutants resistant to 3 /sg/ml of thioguanine were obtained from 5 X 10-cells. After mutagenic treatment (21) Fig. 2 ). The karyotype of these resistant clones was similar to DON (Fig. 1) 10-4. In a mutagen-treated population the frequency of these resistant clones was within a factor of two (13 and 2.3 X 10-4 respectively) that of the untreated sample.
The spontaneous mutants, designated tgsp, were characterized in terms of karyotype (Fig. 1) , efficiency of plating (Fig.  2 ) and reversion rate (Table 4) .
Whereas BrdUrd-resistance may have various causes, i.e., thymidine kinase deficiency in B1 (20) and a deficiency in thymidine transport in DON (27) , it seems that the basis for thioguanine (azaguanine) resistance is in the reduced activity of hypoxanthine phosphoribosyltransferase (25, 28) . In order to determine whether in our thioguanine-resistant strains or their revertants, the phosphoribosyltransferase presented a qualitative alteration, Cellogel electrophoresis was performed according to Shin et al. (29) . The results showed that the stable thioguanine-resistant mutants of DON, tg3, and tg5 had no measurable activity whereas tgsp2 and tgsp8 had a reduced activity without any change in electrophoretic mobility.
S. Mosee Lim ST6H. A thioguanine-resistant mutant of the mouse line 3T6 originally obtained from Dr. H. Green (designated 3T6H) was plated in HAT medium to score for revertants. Out of 4 X 106 3T6H cells, one revertant clone was obtained. This clone, 3T6R1, grew equally well in E4 A HAT. In E4 + thioguanine (thioguanine medium), the plating efficiency relative to E4 (reversion frequency) was 0.06. 3T6R1 was subcultured and maintained both in HAT and E4. Ten days later, the relative plating efficiency in thioguanine-medium (reversion frequency) was found to be a few percent for cells grown in E4 but 10-8 if they had grown in HAT; 2 months later the reversion frequency was 10-5 irrespective of the conditions of growth.
No differences in electrophoretic mobility were found between the hypoxanthine phosphoribosyltransferase of 3T6R1 and of 3T6H cells; there were only differences in the amount. The second class (which includes all other mutants studied in this work) is characterized, albeit transiently, by low plating efficiency, high reversion rate, and karyotypic disturbances.
The fact that the frequency of mutants in this class is not increased by treatment with nitrosoguanidine and the fact that no qualitative alteration was found in the relevant gene product could be an indication that these mutant phenotypes are caused, as suggested by Harris (2) by a "shift in phenotypic expression." However, since there is a correlation with chromosomal variation, there may be behind these shifts, a genetic phenomenon, namely, variations in gene dosage. Furthermore, the higher rate of occurrence of these mutants in permanent cell lines when compared to diploid cultures need not be based on an impaired control in established cell lines since the difference can be attributed to higher variability of gene dosage in these lines.
